SNAI2 and breast cancer: In MCF-7 breast cancer cells, MMP1 is activated by Slug and enhances multidrug resistance; knockdown of Slug reduced MMP1 expression in these cells, further enhancing adriamycin resistance [37]; in immune analysis, in luminal breast cancer, MMP1 is negatively associated with tumor survival.